- Home
- FUTU vs PODD Comparison
FUTU vs PODD Comparison
Compare FUTU & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUTU
- PODD
- Stock Information
- Founded
- FUTU 2011
- PODD 2000
- Country
- FUTU Hong Kong
- PODD United States
- Employees
- FUTU N/A
- PODD N/A
- Industry
- FUTU Investment Bankers/Brokers/Service
- PODD Medical/Dental Instruments
- Sector
- FUTU Finance
- PODD Health Care
- Exchange
- FUTU Nasdaq
- PODD Nasdaq
- Market Cap
- FUTU 19.7B
- PODD 21.5B
- IPO Year
- FUTU 2019
- PODD 2007
- Fundamental
- Price
- FUTU $174.25
- PODD $321.27
- Analyst Decision
- FUTU Strong Buy
- PODD Strong Buy
- Analyst Count
- FUTU 5
- PODD 19
- Target Price
- FUTU $160.38
- PODD $324.68
- AVG Volume (30 Days)
- FUTU 2.2M
- PODD 697.3K
- Earning Date
- FUTU 08-20-2025
- PODD 08-07-2025
- Dividend Yield
- FUTU 1.12%
- PODD N/A
- EPS Growth
- FUTU 58.31
- PODD N/A
- EPS
- FUTU 6.00
- PODD 3.32
- Revenue
- FUTU $1,788,948,850.00
- PODD $2,359,500,000.00
- Revenue This Year
- FUTU $48.32
- PODD $24.54
- Revenue Next Year
- FUTU $10.00
- PODD $17.48
- P/E Ratio
- FUTU $29.10
- PODD $96.68
- Revenue Growth
- FUTU 54.51
- PODD 26.00
- 52 Week Low
- FUTU $56.22
- PODD $180.31
- 52 Week High
- FUTU $179.17
- PODD $329.33
- Technical
- Relative Strength Index (RSI)
- FUTU 67.68
- PODD 67.49
- Support Level
- FUTU $155.28
- PODD $302.41
- Resistance Level
- FUTU $179.17
- PODD $322.80
- Average True Range (ATR)
- FUTU 6.07
- PODD 9.29
- MACD
- FUTU 0.87
- PODD 3.87
- Stochastic Oscillator
- FUTU 87.06
- PODD 96.70
About FUTU Futu Holdings Limited
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and the United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services, and interest income.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.